Mannose-Binding Protein Deficiency
|
0.700 |
Biomarker
|
disease |
BEFREE |
Our study revealed an unexpected function of MBL in drug metabolism, thus providing new insight into the drug-induced liver injury in patients with MBL deficiency.
|
30706943 |
2019 |
Mannose-Binding Protein Deficiency
|
0.700 |
Biomarker
|
disease |
BEFREE |
We propose that MBL may be exploited as a new therapeutic approach in the treatment of chemical-induced sterile liver injury in patients with MBL deficiency.
|
30351498 |
2019 |
Mannose-Binding Protein Deficiency
|
0.700 |
Biomarker
|
disease |
BEFREE |
MBL deficiency has been linked to a more severe course of several infectious diseases and humans with detectable antibodies against B. burgdorferi are significantly more often MBL deficient compared to humans without antibodies against B. burgdorferi.
|
30723261 |
2019 |
Mannose-Binding Protein Deficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
MBL-deficiency, which is associated with MBL2 mutations, was associated with a lower age at diagnosis and with steeper declines in FEV<sub>1</sub> in patients with PCD.
|
31012247 |
2019 |
Mannose-Binding Protein Deficiency
|
0.700 |
Biomarker
|
disease |
BEFREE |
Our study revealed an unexpected function of MBL in osteoclastogenesis, thus providing new insight into inflammatory arthritis and other bone-related diseases in patients with MBL deficiency.
|
31214191 |
2019 |
Mannose-Binding Protein Deficiency
|
0.700 |
Biomarker
|
disease |
BEFREE |
The aim of this study was to ascertain whether mannose binding lectin deficiency is implicated in coexistent rheumatoid arthritis and bronchiectasis and to determine whether undetectable mannose binding lectin confers poorer long-term survival in coexistent rheumatoid arthritis and bronchiectasis or in rheumatoid arthritis in general.
|
30970022 |
2019 |
Mannose-Binding Protein Deficiency
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
In MBL2 variant-type, mannose-binding lectin levels were significantly lower and incidences of mannose-binding lectin deficiency (MBL level<700ng/mL) were higher (p<0.001).
|
31029683 |
2019 |
Mannose-Binding Protein Deficiency
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
Immunoglobulin replacement therapy reduced the rate of infectious complications in PID patients; however, these reductions were more apparent in patients with normal MBL levels than patients with MBL deficiency.
|
29119939 |
2018 |
Mannose-Binding Protein Deficiency
|
0.700 |
Biomarker
|
disease |
BEFREE |
Furthermore, infants born to Group A mothers with MBL deficiency (n = 13, MBL ≤100 ng/mL) had significantly lower birthweights, compared to those born to Group A women with normal MBL serum concentrations (P < .0001).
|
29758096 |
2018 |
Mannose-Binding Protein Deficiency
|
0.700 |
Biomarker
|
disease |
BEFREE |
In conclusion, MBL deficiency and MBL excess may both have deleterious effects on IgAN progression, which suggests that MBL contributes to IgAN pathogenesis through multiple mechanisms.
|
28698271 |
2017 |
Mannose-Binding Protein Deficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The results suggest that MBL deficiency and the presence of MBL2 gene polymorphisms that lead to MBL deficiency are risk factors for the occurrence of miscarriage in patients with RA.
|
28898115 |
2017 |
Mannose-Binding Protein Deficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
MBL deficiency is usually caused by mutations in exon 1 of the MBL structural gene (MBL2).
|
27624657 |
2017 |
Mannose-Binding Protein Deficiency
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Long-term Clinical Outcome of Antibody Replacement Therapy in Humoral Immunodeficient Adults With Respiratory Tract Infections.
|
28347655 |
2017 |
Mannose-Binding Protein Deficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Genetic sequencing in 77 consecutive patients with IMN identified four patients with MBL2 promoter and coding region variations associated with MBL deficiency and the same complement pattern in immune deposits as the index patient.
|
27153925 |
2016 |
Mannose-Binding Protein Deficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, cardiac patients with genotypes causing MBL deficiency presented less heart damage (P = 0.003, OR = 0.23), compared with cardiac patients having the XA haplotype causing low MBL levels, but fully capable of activating complement (P = 0.005, OR = 7.07).
|
26745156 |
2016 |
Mannose-Binding Protein Deficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
However, there was no association of MBL deficiency (<0.5 μg/ml), MBL2 haplo- or genotypes with IAC.
|
26730718 |
2016 |
Mannose-Binding Protein Deficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
These haplotypes comprise polymorphisms in the MBL2 gene and promoter region and are known to result in varying levels of MBL deficiency.
|
27315016 |
2016 |
Mannose-Binding Protein Deficiency
|
0.700 |
Biomarker
|
disease |
BEFREE |
Prevalence of plasma MBL deficiency (less than 100 μg/L) and MBL2 deficient genetic variants (A/O and O/O genotypes) was 21% (42 out of 197) and 39% (74 out of 190), respectively.
|
26348711 |
2015 |
Mannose-Binding Protein Deficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We calculated and compared the proportions of plasma MBL deficiency, MBL2 structural variant alleles B (codon 54A>G), C (codon 57A>G), and D (codon 52T>C) as well as MBL2 promoter variants -550(H/L), -221(X/Y) and +4(P/Q) between HIV-1 and schistosoma co-infection and control groups using Chi Square test.
|
25830474 |
2015 |
Mannose-Binding Protein Deficiency
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
Our study further supports the notion that neonates with MBL deficiency and low MBL serum levels at birth may be at higher risk of developing severe respiratory complications.
|
25879044 |
2015 |
Mannose-Binding Protein Deficiency
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
However, there was a trend towards higher median MBL levels in cases with late AMD compared to cases with early AMD (1.0 vs. 0.4 μg/ml, p = 0.09) and MBL deficiency (<0.5 μg/ml) was encountered less frequently in the late AMD group (35% vs 56%, p = 0.03).
|
26207622 |
2015 |
Mannose-Binding Protein Deficiency
|
0.700 |
Biomarker
|
disease |
BEFREE |
Individuals homozygous or heterozygous for any of three variant alleles of MBL2 (O/O or A/O genotypes) have deficient concentrations of MBL2 in circulating blood, but previous studies linking MBL deficiency to susceptibility to meningococcal disease have not revealed a consistent association.
|
24977653 |
2014 |
Mannose-Binding Protein Deficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
As mannose-binding lectin (MBL) is involved in such processes, we hypothesized that the variants in the MBL2 gene resulting in MBL deficiency confer an increased risk of nephritis in systemic lupus erythematosus (SLE).
|
24850777 |
2014 |
Mannose-Binding Protein Deficiency
|
0.700 |
Biomarker
|
disease |
BEFREE |
Significant differences in MBL and MASP-2 concentrations were observed between cohorts, especially an intriguing finding associating panic disorder with MBL deficiency.
|
24856568 |
2014 |
Mannose-Binding Protein Deficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We used the Nigerian cohort from our recently published study, which included 163 Schistosoma haematobium-infected individuals and 183 matched healthy subjects, and investigated whether MBL deficiency and MBL2 polymorphisms are associated with schistosomiasis.
|
23448728 |
2013 |